Aspirin could cut the risk of death from cancers by 20%, study finds
Sarah Williams from Cancer Research UK welcomes a report that suggests a daily dose of Aspirin could ward of cancer but says there is still the question of side effects.
Experts found a 20% reduction in mortality in patients with cancer taking aspirin
They found that the benefit appears not to be restricted 'to one or a few cancers'
The cheap drug reduces 'metastatic spread' - the spread of cancer in the body
Aspirin is commonly known as a cheap and effective over-the-counter painkiller, but a new study suggests it is also a successful cancer treatment option too.
Academics at Cardiff University carried out a review of prior observational studies in patients with 18 different cancers, including breast, colon and prostate.
Out of around 250,000 patients, taking aspirin was associated with a reduction of about 20 per cent in cancer deaths, compared to those who didn't take the drug.
Aspirin reduces 'metastatic spread' – the spread of cancer within the body, the academics say.
They added that 'serious consideration' should therefore be given regarding the use of aspirin alongside – but not instead of – other therapies to treat cancer.
Patients with cancer should be encouraged to raise the topic of aspirin taking with their doctors, the researchers said.